But it's important to understand the differences between treating RA with these newer medications and treating it with traditional disease-modifying anti-rheumatic drugs (DMARDs). RA treatment has made major strides over the past few decades — first with the use of DMARDs and then with the introduction of biologics. Retinal toxicity and plaquenil Plaquenil chronic urticaria What does hydroxychloroquine do for lupus Hydroxychloroquine HCQ- Plaquenil Hydroxychloroquine is an antimalarial drug, sold under the trade names Plaquenil, Axemal in India, Dolquine and Quensyl, also used to reduce inflammation in the treatment of rheumatoid arthritis see disease-modifying antirheumatic drugs and lupus. Hydroxychloroquine is also an antimalarial medicine used to prevent and treat malaria and other parasitic infections. It is not used routinely now for this purpose because of resistance by the parasites. It is not clear how hydroxychloroquine works in inflammatory conditions; however it is thought to have an action on the immune system. In The British Society for Rheumatology BSR has published updated guidelines on the prescribing and monitoring of DMARDs, which include recommendations for more intensive screening for retinal toxicity in patients on antimalarials. The advice represents a significant shift in practice and results in a substantial additional workload for. "Today, we can change the course of this disease with newer treatment options."DMARDs are drugs that can help prevent joint damage and deformity from RA. Although biologic drugs are technically a type of DMARD, they're usually just called biologics, which helps distinguish them from traditional DMARDs.“When I started treating rheumatoid arthritis more than 25 years ago, we were limited to relieving pain and swelling with non-steroidal anti-inflammatory drugs (NSAIDs) and steroids," says Stuart Kaplan, MD, chief of rheumatology at South Nassau Communities Hospital in Oceanside, New York. Nonbiological dmard antimalarial hydroxychloroquine plaquenil Antimalarials, ATIENT NFORMATION ON HYDROXYCHLOROQUINE Sarcoidosis treatment hydroxychloroquinePlaquenil skin cancerHydroxychloroquine dose based on weight and renal function Plaquenil is the brand name for the prescription drug hydroxychloroquine. It's used to treat and prevent malaria infection, and to reduce symptoms and progression of autoimmune diseases such as lupus, rheumatoid arthritis, and others. Plaquenil Hydroxychloroquine - Side Effects, Dosage.. Monitoring for retinal toxicity in patients taking hydroxychloroquine.. Mechanism of action of hydroxychloroquine as an.. The two most commonly used antimalarials in the treatment of psoriatic arthritis are Plaquenil ® hydroxychloroquine and Aralen ® chloroquine phosphate. Aralen has not been approved by the U. S. Food and Drug Administration FDA to treat conditions other than malaria. Evaluation of a patient decision aid PtDA for initiating disease modifying anti–rheumatic drugs. The PtDA can be a valuable aid in improving patient participation in decision–making about disease modifying anti–rheumatic drugs DMARDs. BioMed Central, Arthritis Research & Therapy, 10/28/2016. Hydroxychloroquine is a quinoline medicine used to treat or prevent malaria, a disease caused by parasites that enter the body through the bite of a mosquito. Malaria is common in areas such as Africa, South America, and Southern Asia. This medicine is not effective against all strains of malaria.